Goldman Sachs Says Curing Diseases May Not Be Economically Viable

A leaked report has stated what many in the health industry have whispered privately; there is a lot less money in curing people than in long-term management of disease. The issue is brought into focus by the possibility of a gene therapy that could soon cure a large variety of genetic conditions by changing individual units of DNA. However, the huge potential boon for society could be blocked without changes to the way health is funded. Countries with public health systems may be able to reap the benefits of the new technologies, leaving the US trailing in their wake.

http://www.iflscience.com/health-and-medicine/goldman-sachs-says-curing-diseases-may-not-be-economically-valid/all/